Soluble Mesothelin, Megakaryocyte Potentiating Factor, and Osteopontin as Markers of Patient Response and Outcome in Mesothelioma

MLA

Paul Germonpré, et al. “Soluble Mesothelin, Megakaryocyte Potentiating Factor, and Osteopontin as Markers of Patient Response and Outcome in Mesothelioma.” Journal of Thoracic Oncology, vol. 6, Nov. 2011, pp. 1930–37. EBSCOhost, https://doi.org/10.1097/jto.0b013e3182272294.

APA

Paul Germonpré, Robert Gosselin, Lionel Bosquée, Yoshiro Kishi, Jan P. van Meerbeeck, Paul De Vuyst, Kristiaan Nackaerts, Eliane Kellen, Walter De Wever, Joris R. Delanghe, Kevin Hollevoet, & Catherine Legrand. (2011). Soluble Mesothelin, Megakaryocyte Potentiating Factor, and Osteopontin as Markers of Patient Response and Outcome in Mesothelioma. Journal of Thoracic Oncology, 6, 1930–1937. https://doi.org/10.1097/jto.0b013e3182272294

Chicago

Paul Germonpré, Robert Gosselin, Lionel Bosquée, Yoshiro Kishi, Jan P. van Meerbeeck, Paul De Vuyst, Kristiaan Nackaerts, et al. 2011. “Soluble Mesothelin, Megakaryocyte Potentiating Factor, and Osteopontin as Markers of Patient Response and Outcome in Mesothelioma.” Journal of Thoracic Oncology 6 (November): 1930–37. doi:10.1097/jto.0b013e3182272294.